NASDAQ:BRKR - Bruker Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$39.26 +0.39 (+1.00 %)
(As of 03/18/2019 04:00 PM ET)
Previous Close$38.87
Today's Range$38.61 - $39.29
52-Week Range$26.10 - $39.29
Volume870,400 shs
Average Volume676,852 shs
Market Capitalization$6.15 billion
P/E Ratio28.04
Dividend Yield0.41%
Beta1.47
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostic, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. It has a strategic partnership with Mestrelab Research SL. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.90 billion
Cash Flow$1.8830 per share
Book Value$5.78 per share

Profitability

Net Income$179.70 million

Miscellaneous

Employees6,200
Market Cap$6.15 billion
Next Earnings Date5/2/2019 (Estimated)
OptionableOptionable

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Friday, February 15th. Investors of record on Tuesday, March 5th will be paid a dividend of $0.04 per share on Friday, March 22nd. This represents a $0.16 dividend on an annualized basis and a yield of 0.41%. The ex-dividend date of this dividend is Monday, March 4th. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker announced that its board has authorized a share repurchase program on Sunday, June 4th 2017, which authorizes the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings data on Monday, February, 11th. The medical research company reported $0.54 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.54. The medical research company earned $553.60 million during the quarter, compared to analysts' expectations of $544.53 million. Bruker had a net margin of 9.48% and a return on equity of 26.36%. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Bruker.

What guidance has Bruker issued on next quarter's earnings?

Bruker updated its FY 2019 earnings guidance on Monday, February, 11th. The company provided earnings per share guidance of $1.54-1.58 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.55. The company issued revenue guidance of $2.009-2.028 billion, compared to the consensus revenue estimate of $1.97 billion.

What price target have analysts set for BRKR?

5 Wall Street analysts have issued 12-month price targets for Bruker's shares. Their predictions range from $30.00 to $44.00. On average, they anticipate Bruker's share price to reach $35.80 in the next year. This suggests that the stock has a possible downside of 8.8%. View Analyst Price Targets for Bruker.

What is the consensus analysts' recommendation for Bruker?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 1 hold rating, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker.

Has Bruker been receiving favorable news coverage?

Media headlines about BRKR stock have been trending somewhat positive this week, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Bruker earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave news coverage about the medical research company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 56)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 63)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 60)
  • Stacey Desrochers, Treasurer & Director of Investor Relations

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (4.24%), BlackRock Inc. (3.49%), Acadian Asset Management LLC (2.55%), D. E. Shaw & Co. Inc. (1.36%), Norges Bank (1.06%) and Bank of America Corp DE (0.86%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker.

Which major investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Acadian Asset Management LLC, BTIM Corp., Prudential Financial Inc., QS Investors LLC, Citigroup Inc., D. E. Shaw & Co. Inc. and Bank of Montreal Can. View Insider Buying and Selling for Bruker.

Which major investors are buying Bruker stock?

BRKR stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, First Trust Advisors LP, Thrivent Financial for Lutherans, Bank of America Corp DE, Mackay Shields LLC, Segantii Capital Management Ltd, Millennium Management LLC and Canada Pension Plan Investment Board. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $39.26.

How big of a company is Bruker?

Bruker has a market capitalization of $6.15 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

What is Bruker's official website?

The official website for Bruker is http://www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (NASDAQ BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  543 (Vote Outperform)
Underperform Votes:  591 (Vote Underperform)
Total Votes:  1,134
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel